Changes to the ways in which the FDA plans to regulate vaccines represent a threat to effective vaccines and public health, ...

A recent memo from an FDA vaccine division director has reignited debate about COVID-19 immunization for children. The ...

The minimum condition for the offer has been satisfied, with 184,071,410 shares of CureVac, representing approximately 81.74% of CureVac’s issued ...

The "Vaccine Development Companies Landscape: Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ...

A dozen prior leaders of the U.S. Food and Drug Administration issued a scathing denunciation of an FDA memo to staff that ...

Americans’ confidence in the Centers for Disease Control and Prevention has plummeted, according to a 2025 National ...

In a New England Journal of Medicine article, the former FDA commissioners wrote they were “deeply concerned” by the top vaccine regulator’s approach to raising the bar for approvals.

Twelve former U.S. FDA commissioners said on Wednesday they were deeply concerned about proposed changes to U.S. vaccine ...

Mixed options sentiment in Pfizer (PFE), with shares up 52c, or 2.09%, near $25.68. Options volume relatively light with 73k contracts traded and ...

The vaccine advisory committee of the Centers for Disease Control and Prevention is scheduled to meet Dec. 4 and 5. On the ...

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...